Information note on the use of delamanid in children and adolescents with multidrug- and rifampicin-resistant tuberculosis, March 2023

Information note on the use of delamanid in children and adolescents with multidrug- and rifampicin-resistant tuberculosis, March 2023 PDF Author: World Health Organization
Publisher: World Health Organization
ISBN: 9240074309
Category : Medical
Languages : en
Pages : 8

Get Book Here

Book Description

Information note on the use of delamanid in children and adolescents with multidrug- and rifampicin-resistant tuberculosis, March 2023

Information note on the use of delamanid in children and adolescents with multidrug- and rifampicin-resistant tuberculosis, March 2023 PDF Author: World Health Organization
Publisher: World Health Organization
ISBN: 9240074309
Category : Medical
Languages : en
Pages : 8

Get Book Here

Book Description


Use of bedaquiline in children and adolescents with multidrug- and rifampicin-resistant tuberculosis – Information note

Use of bedaquiline in children and adolescents with multidrug- and rifampicin-resistant tuberculosis – Information note PDF Author: World Health Organization
Publisher: World Health Organization
ISBN: 9240074287
Category : Medical
Languages : en
Pages : 8

Get Book Here

Book Description


WHO consolidated guidelines on drug-resistant tuberculosis treatment

WHO consolidated guidelines on drug-resistant tuberculosis treatment PDF Author: World Health Organization
Publisher: World Health Organization
ISBN: 9789241550529
Category : Medical
Languages : en
Pages : 0

Get Book Here

Book Description
Tuberculosis (TB) strains with drug resistance (DR-TB) are more difficult to treat than drug-susceptible ones, and threaten global progress towards the targets set by the End TB Strategy of the World Health Organization (WHO). There is thus a critical need for evidence-based policy recommendations on the treatment and care of patients with DR-TB, based on the most recent and comprehensive evidence available. In this regard, the WHO consolidated guidelines on drug-resistant tuberculosis treatment fulfil the mandate of WHO to inform health professionals in Member States on how to improve treatment and care for patients with DR-TB. Between 2011 and 2018, WHO has developed and issued evidence-based policy recommendations on the treatment and care of patients with DR-TB. These policy recommendations have been presented in several WHO documents and their associated annexes, including the WHO treatment guidelines for multidrug- and rifampicin-resistant tuberculosis, 2018 update, issued by WHO in December 2018. The policy recommendations in each of these guidelines have been developed by WHO-convened Guideline Development Groups (GDGs), using the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) approach to summarize the evidence, and formulate policy recommendations and accompanying remarks. The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB, including longer and shorter regimens, culture monitoring of patients on treatment, the timing of antiretroviral therapy (ART) in MDR/RR-TB patients infected with the human immunodeficiency virus (HIV), use of surgery for patients receiving MDR-TB treatment, and optimal models of patient support and care.

Disease Control Priorities, Third Edition (Volume 6)

Disease Control Priorities, Third Edition (Volume 6) PDF Author: King K. Holmes
Publisher: World Bank Publications
ISBN: 1464805253
Category : Medical
Languages : en
Pages : 1027

Get Book Here

Book Description
Infectious diseases are the leading cause of death globally, particularly among children and young adults. The spread of new pathogens and the threat of antimicrobial resistance pose particular challenges in combating these diseases. Major Infectious Diseases identifies feasible, cost-effective packages of interventions and strategies across delivery platforms to prevent and treat HIV/AIDS, other sexually transmitted infections, tuberculosis, malaria, adult febrile illness, viral hepatitis, and neglected tropical diseases. The volume emphasizes the need to effectively address emerging antimicrobial resistance, strengthen health systems, and increase access to care. The attainable goals are to reduce incidence, develop innovative approaches, and optimize existing tools in resource-constrained settings.

Global Tuberculosis Report 2019

Global Tuberculosis Report 2019 PDF Author: World Health Organization
Publisher:
ISBN: 9789241565714
Category :
Languages : en
Pages : 294

Get Book Here

Book Description
WHO has published a global TB report every year since 1997. The main aim of the report is to provide a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of recommended global TB strategies and targets endorsed by WHO?s Member States, broader development goals set by the United Nations (UN) and targets set in the political declaration at the first UN high-level meeting on TB (held in September 2018). The 2019 edition of the global TB report was released on 17 October 2019. The data in this report are updated annually. Please note that direct comparisons between estimates of TB disease burden in the latest report and previous reports are not appropriate. The most recent time-series of estimates are published in the 2019 global TB report.

WHO consolidated guidelines on tuberculosis. Module 4

WHO consolidated guidelines on tuberculosis. Module 4 PDF Author: World Health Organization
Publisher: World Health Organization
ISBN: 924004812X
Category : Medical
Languages : en
Pages : 72

Get Book Here

Book Description
Between 2011 and 2019, WHO has developed and issued evidence-based policy recommendations on the treatment and care of patients with DR-TB. These policy recommendations have been presented in several WHO documents and their associated annexes, including the WHO Consolidated Guidelines on Drug Resistant Tuberculosis Treatment, issued by WHO in March 2019. The policy recommendations in each of these guidelines have been developed by WHO-convened Guideline Development Groups, using the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) approach to summarize the evidence, and formulate policy recommendations and accompanying remarks. The present WHO Consolidated Guidelines on Tuberculosis, Module 4: Treatment - Drug-Resistant Tuberculosis Treatment includes a comprehensive set of WHO recommendations for the treatment and care of DR-TB. The document includes two new recommendations, one on the composition of shorter regimens and one on the use of the BPaL regimen (i.e. bedaquiline, pretomanid and linezolid). In addition, the consolidated guidelines include existing recommendations on treatment regimens for isoniazid-resistant TB and MDR/RR-TB, including longer regimens, culture monitoring of patients on treatment, the timing of antiretroviral therapy (ART) in MDR/RR-TB patients infected with the human immunodeficiency virus (HIV), the use of surgery for patients receiving MDR-TB treatment, and optimal models of patient support and care. The guidelines are to be used primarily in national TB programmes, or their equivalents in Ministries of Health, and for other policy-makers and technical organizations working on TB and infectious diseases in public and private sectors and in the community.

Global Tuberculosis Report 2015

Global Tuberculosis Report 2015 PDF Author: World Health Organization
Publisher: World Health Organization
ISBN: 9241565055
Category : Medical
Languages : en
Pages : 204

Get Book Here

Book Description
Chapter 1. Introduction -- chapter 2. Disease burden and 2015 targets assessment -- chapter 3. TB case notifications and treatment outcomes -- chapter 4. Drug-resistant TB -- chapter 5. Diagnostics and laboratory strengthening -- chapter 6. Addressing the co-epidemics of TB and HIV -- chapter 7. Financing -- chapter 8. Research and development -- Annexes.

Antibiotic and Antifungal Therapies in Dermatology

Antibiotic and Antifungal Therapies in Dermatology PDF Author: Jón Hjaltalín Ólafsson
Publisher: Springer
ISBN: 331939424X
Category : Medical
Languages : en
Pages : 349

Get Book Here

Book Description
This book is an up-to-date practical guide to the treatment of both common and unusual bacterial, fungal, and protozoal skin infections. Antibiotics and other treatment options for common skin diseases such as acne, rosacea, erysipelas, and impetigo are extensively discussed, and a thorough update is provided on therapies for fungal infections in the nails, hair, and skin. Current treatments for skin symptoms associated with sexually transmitted diseases are also explored in detail. A range of mycobacterial infections are discussed, and a further chapter considers the treatment of protozoal infections, including leishmaniasis, which are often unfamiliar to practitioners in the Western world. This handy book, with its helpful graphics and clear lists of symptoms, treatments, and practical tips, will be an ideal quick reference for the busy practitioner.

Oxford Handbook of Infectious Diseases and Microbiology

Oxford Handbook of Infectious Diseases and Microbiology PDF Author: Estée Török
Publisher: Oxford University Press
ISBN: 019967132X
Category : Anti-infective agents
Languages : en
Pages : 914

Get Book Here

Book Description
This handbook takes an integrated approach to both infectious disease and microbiology. Referenced to national frameworks and current legislation, it covers basic principles of bacteriology and virology, specific information on diseases and conditions, and material on 'hot topics' such as bioterrorism and preventative medicine.

Promoting Access to Medical Technologies and Innovation - Intersections between Public Health, Intellectual Property and Trade

Promoting Access to Medical Technologies and Innovation - Intersections between Public Health, Intellectual Property and Trade PDF Author: World Intellectual Property Organization
Publisher: WIPO
ISBN: 9280523082
Category : Law
Languages : en
Pages : 259

Get Book Here

Book Description
This study has emerged from an ongoing program of trilateral cooperation between WHO, WTO and WIPO. It responds to an increasing demand, particularly in developing countries, for strengthened capacity for informed policy-making in areas of intersection between health, trade and IP, focusing on access to and innovation of medicines and other medical technologies.